Citation: C. Linden et A. Alm, LATANOPROST TWICE-DAILY IS LESS EFFECTIVE THAN ONCE-DAILY - INDICATION OF RECEPTOR SUBSENSITIVITY, Current eye research, 17(6), 1998, pp. 567-572
Authors:
AHLM C
LINDEN C
LINDERHOLM M
ALEXEYEV OA
BILLHEDEN J
ELGH F
FAGERLUND M
ZETTERLUND B
SETTERGREN B
Citation: C. Ahlm et al., CENTRAL-NERVOUS-SYSTEM AND OPHTHALMIC INVOLVEMENT IN NEPHROPATHIA-EPIDEMICA (EUROPEAN TYPE OF HEMORRHAGIC-FEVER WITH RENAL SYNDROME), The Journal of infection, 36(2), 1998, pp. 149-155
Citation: C. Linden et A. Alm, EFFECTS ON INTRAOCULAR-PRESSURE AND AQUEOUS FLOW OF VARIOUS DOSE REGIMENS OF LATANOPROST IN HUMAN EYES, Acta ophthalmologica Scandinavica, 75(4), 1997, pp. 412-415
Authors:
THATCHER RW
CAMACHO M
SALAZAR A
LINDEN C
BIVER C
CLARKE L
Citation: Rw. Thatcher et al., QUANTITATIVE MRI OF THE GRAY-WHITE MATTER DISTRIBUTION IN TRAUMATIC BRAIN INJURY, Journal of neurotrauma, 14(1), 1997, pp. 1-14
Citation: C. Linden et A. Alm, EFFECT OF CONSECUTIVELY APPLIED FLUORESCEIN EYE DROPS ON CORNEAL AND AQUEOUS CONCENTRATIONS OF FLUORESCEIN, Ophthalmic research, 29(2), 1997, pp. 57-60
Citation: C. Linden et al., EFFECTS ON IOP RESTORATION AND BLOOD-AQUEOUS BARRIER AFTER LONG-TERM TREATMENT WITH LATANOPROST IN OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION, British journal of ophthalmology, 81(5), 1997, pp. 370-372
Citation: C. Linden et A. Alm, LATANOPROST AND PHYSOSTIGMINE HAVE MOSTLY ADDITIVE OCULAR HYPOTENSIVEEFFECTS IN HUMAN EYES, Archives of ophthalmology, 115(7), 1997, pp. 857-861
Authors:
CAMRAS CB
ALM A
WATSON P
STJERNSCHANTZ J
AASVED H
JANGARD P
LUNDANDERSEN H
FLESNER P
SODERSTROM M
EHINGER B
HOLMIN C
BENGTSSONSTIGMAR E
HEIJL A
GUNDERSEN KG
AIRAKSINEN J
TUULONEN A
HALSEIDE R
LINDBLOM B
RINGVOLD A
VEGGE T
LINDEN C
NILSSON SE
FRISTROM B
WIDENGARD I
THYGESEN J
GREEN F
VALENZUELA F
POTTS M
SPENCER I
COAKES R
REYNOLDS P
MILLS B
CHATTERJEE A
NAGASUBRAMANIAN S
ROXBURGH S
SANDERS R
BAILEY M
WHYTE IF
VERNON S
SLOPER M
MURRAY S
DAVEY C
HICKMANCASEY J
LONGSTAFF S
CURRIE Z
WISHART P
AUSTIN M
BIRCH M
ELKINGTON A
LUFF A
BECK L
BLACKMORE M
CIOFFI GA
VANBUSKIRK EM
FRASER J
STEWART JA
LUSTGARTEN J
SCHUMER RA
PODOS SM
ARROYO M
NITZBERG S
RITCH R
ABUNDO G
CARONIA R
LIEBMANN J
STEINBERGER D
KRUPIN T
ROSENBERG LF
RUDERMANN JM
CLARKSON K
WEINREB R
OCHABSI R
SHERWOOD M
SMITH MF
STOKES DW
ZAM ZA
WILENSKY J
HILLMAN D
KAPLAN B
GATES V
NAIL C
ZIMMERMAN T
FECHTNER R
FENTON R
FENTON J
HIGGINBOTHAM EJ
JOHNSON AT
POLLACKRUNDLE CJ
WEISS E
YABLONSKI ME
TANNENBAUM MH
IBRAHIM F
OHIA E
NEELEY D
MINCKLER D
HEUER D
LEE P
PADEA M
KAUFMAN PL
HEATLEY GA
VANDERHOFYOUNG MA
WAX M
JONES A
KATZ LJ
MOSTER M
PARKER B
ROBIN AL
JUZYCH M
BRUMMETT M
Citation: Cb. Camras et al., LATANOPROST, A PROSTAGLANDIN ANALOG, FOR GLAUCOMA THERAPY - EFFICACY AND SAFETY AFTER 1 YEAR OF TREATMENT IN 198 PATIENTS, Ophthalmology, 103(11), 1996, pp. 1916-1924
Authors:
ALM A
STJERNSCHANTZ J
WIDENGARD I
LINDEN C
SODERSTROM M
NILSSON SE
FRISTROM B
LINDBLOM B
HEIJL A
GUNDERSEN KG
EHINGER B
HOLMIN C
BENGTSSONSTIGMAR E
AASVED H
JANGARD P
RINGVOLD A
VEGGE T
HALSEIDE R
LUNDANDERSEN H
FLESNER P
THYGESEN J
AIRAKSINEN J
TUULONEN A
Citation: A. Alm et al., EFFECTS ON INTRAOCULAR-PRESSURE AND SIDE-EFFECTS OF 0.005-PERCENT LATANOPROST APPLIED ONCE-DAILY, EVENING OR MORNING - A COMPARISON WITH TIMOLOL, Ophthalmology, 102(12), 1995, pp. 1743-1752